Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

NCT01189929

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • The Austin Hospital Heidelberg, Victoria, Australia
  • Christchurch Hospital Christchurch, New Zealand
View Trial Details
Completed

Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

NCT00267020

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Dallas, Texas, United States
View Trial Details
Completed

Pancreas Resection With and Without Drains

NCT01441492

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • University of Florida Health Gainesville, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Indiana University - Purdue University Indianapolis Indianapolis, Indiana, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View all 14 locations
View Trial Details

Related conditions